Wim Weyenberg, PharmD, MS, RPh, BBA, PhD
Married with 3 sons
Dr. Wim Weyenberg has gained over 16 years’ experience within the pharmaceutical industry on multiple Therapeutic Areas and with variety roles and responsibilities, including Medical Affairs, Market Access, Patient Liaison Programs, Life Cycle Management, Project Management and Pharmaceutical Development.
Wim is Senior Director in the Specialty Life Cycle Management Division at Teva Pharmaceuticals and responsible for the Life Cycle Management and Compound Strategy Programs where he leads the cross-functional Specialty Life Cycle teams working on CNS, Women’s Health and Oncology and supports, plans and drives the compound developmental innovations. He started his career as Project Team Lead at Johnson & Johnson, working in the R&D division. Progressing to a career in management consulting and working at IMS Health, he advised as Senior Consultant international clients across the Pharmaceutical and Healthcare industries, with a focus on Product and Portfolio Strategy and Development. In 2010, he joined Shire Pharmaceutical where he led the Regional Medical Affairs and Market Access activities in Belgium, the Netherlands and Switzerland, for the Orphan Drugs in the area of rare diseases, including Fabry disease, Hunter Syndrome and Gaucher disease.
He graduated with a Pharm. D. and obtained his Ph.D. in Pharmaceutics at the University of Antwerp in Belgium. He also completed postgraduate studies in Business Administration.
Global Director Amsterdam, Wilrijk, Basel
Since January 2013
Global Director, Life Cycle Management, TEVA, Global/EU HQ in Amsterdam (2013-present)
Lead, plan and manage the proposition of modules and implementation of global improvement project strategies (US, EU and Growth Markets) to maximize the life cycles of 14 specialty products (CNS/Multiple Sclerosis, Respiratory, Oncology, Women’s Health) along with project resolutions with internal and external partners. Cultivation of business partnerships to support Life Cycle and Project Management ideas and activities with different internal stakeholders, including R&D, Intellectual Property, Business Development, Commercial, Patient Value, Market Access, Regulatory Affairs, Market Intelligence, Governmental Affairs and Medical Affairs.
Regional Medical Lead - Medical Affairs Benelux-Swi Brussels, Belgium
December 2010 --- March 2013
Senior Medical Affairs Manager, SHIRE, in Brussels (2010-2013)
Regional Medical Affairs Lead for the Medical Affairs and Market Access project activities in the area of BeNeLux (Belgium, the Netherlands and Luxemburg) and Switzerland in the European Shire Rare Disease business area. Contribution to the medical and market access activities for the biotech products VPRIV (Gaucher), Replagal (Fabry), Elaprase (Hunter) and Firazyr (HAE). Development of professional relationships with KOLs and other key customers (including facilitating their involvement in both pharma projects and in investigator sponsored trials) in conjunction with Global Medical Affairs and along with the three Local Operating Companies (LOCs) in Belgium, Netherlands and Switzerland.
Overview and management of the market access and medical aspects of national symposia, advisory boards, workshops, satellite symposia and other meetings.
Senior Consultant - Product & Portfolio Strategy Brussels / London
February 2007 --- December 2010
Senior Management Consultant at Product and Portfolio Strategy, IMS Health consulting, in Brussels/Belgium and London/UK (2007-2010)
Involved as Senior Management Consultant of the Global Product and Portfolio Strategy consulting unit of IMS Health, in global pharma consulting project engagements including optimization brand management, market forecasting, business intelligence, due diligence, portfolio management, and in-licensing and out-licensing compounds for tier pharmaceutical companies (Abbott, Genzyme, GSK, Novartis, Roche, Pfizer, Sanofi-Pasteur MSD, Sanofi-Aventis, Bayer-Schering, Novo-Nordisk, Schering-Plough, Almirall, Forest Pharmaceuticals,…) and international investment companies or organizations (eg. Bill & Melinda Gates Foundation).
Wim was the Global Expert of Ophthalmology at IMS and was involved in consulting and business development engagements with Allergan, Alcon, Pfizer, Santen and Thrombogenics.
He provided insights and advise to marketing managers/directors/vice-presidents, clinical trial managers, business development people and medical managers/directors in the following areas: CNS, ophthalmology, oncology, anti-infectives, vaccines, cardiology, respiratory, generics and diabetes.
Project Lead Beerse, Belgium
September 2005 --- February 2007
R&D Project Leader at J&J (div. of Janssen Pharmaceutica), Beerse, Belgium (2005-2007)
Technical Team lead responsible for the management of the product development programs and clinical manufacturing activities (tablets, capsules, IV solutions, nanosuspensions, etc…) to support clinical phase I and II studies. Contribution to the preparation of Investigation Brochures, CTA, CTSP, PD-TECH, and study protocols.
Assistant Galenics Antwerp, Belgium
September 2000 --- September 2005
PhD student and assistant Galenics (Pharmaceutical Technology) with preparation of PhD thesis at the University of Antwerp and the University of Ghent (2000-2005)
Managed the product development and manufacturing of ocular gelling minitablets based on different mixtures of polymers for the treatment of eye infections. Several concepts were developed, tested and evaluated in three clinical Proof of Concept trials at the University Hospitals of Antwerp and Ghent. The facilities of the companies IBA-Mediris (Fleurus, Belgium) and Fitzpatrick (Sint-Niklaas, Belgium) were used for the sterilisation and up-scaling of the production of the ocular minitablets.
Analytical thinkingInterest in knowledgePerspectiveStrategic thinkingWillingness to compromiseResult OrientedSelf-disciplineResponsibilityInnovative thinkingFlexibilityCuriosityCreative thinkingCoordinationCommunicativeCollaborationCharmAttention to detailTrust
Diabetes Biochemistry R&D NegotiationPresentationsPricingProblem SolvingProblem-solving methods and troubleshootingProduct developmentProduct launchProduct managementProduct MarketingProgram ManagementProject PlanningProject ManagementProject Portfolio ManagementRegulatory StrategiesRespiratoryscienceStrategic PlanningStrategyTeam LeadershipTeam ManagementTeamworkTechnology DevelopmentTechnological InnovationUrologyVaccinesWomens HealthpharmacologyPharmacistsPharmaceuticalsPharmaceuticsOphthalmologyoncologyNew Business DevelopmentNeuroscienceNeurologyNanotechnologyMS ProjectMicrosoft WordMicrosoft ProjectMedical budget managementMedical affairsLife SciencesLeadershipKOL managementImmunologyEntrepreneurshipEnglishDue DiligenceDrug DevelopmentDrug AccountabilityDiabetesCompetitive AnalysisCNSBusiness DevelopmentBusiness IntelligenceBusiness ProcessBudget Management
Skills and Expertise
Analytical skillsDevelop business planEvaluate licensing opportunitiesForecasting of drug productIdentify market opportunitiesInteract with pharmacistsInteract with physiciansLead teamslifesciencePatient liaisonproject managementPromotional materialsStudy execution plan
PhD in Pharmaceutics from University of Antwerp in 2005
Master Industry Pharmacy in Pharmaceutical Sciences from University of Antwerp in 2001
PharmD in Pharmacy from University of Antwerp in 2000
Training and Certification
PhD in 2005 Certification